Mangosteen.
Queen of fruits. Xanthone antioxidants. Mangosteen rind carries xanthones, mainly alpha-mangostin. They are studied for antioxidant and inflammatory signalling, and how well a product dissolves them decides what you absorb.
Reviewed March 2026
- Category
- Compound
- Also filed under
- AntioxidantInflammationXanthones
What Mangosteen is, and what it does.
- Does it work
- Suits active people who want a less common polyphenol alongside training. Check whether you have a pericarp extract or a whole-fruit powder, because they are different materials.
- How much to take
- Start with 200 to 500mg a day of pericarp extract, the daily maintenance band. The 1,000mg used in studies is a research condition, not a daily target. Take it with fat.
- Time to feel it
- Not a same-day thing. Studies tracking antioxidant and inflammatory markers with xanthone material run four to twelve weeks, so the timeline is measured in weeks.
- The first dose
- Day one is mostly about taste and timing. Taken with a meal containing fat it absorbs better, and the rind material is noticeably tart and resinous.
- With regular use
- Weeks of daily use is where the human work sits, four to twelve weeks, tracking antioxidant and inflammatory markers. Those are markers rather than measured outcomes.
- How well tolerated
- Well tolerated in the trials on record, with mild stomach upset the usual note. Tell your clinician if you take daily medicines, since xanthones lean on liver conjugation.
- How it feels
- Subtle. Most people describe no distinct sensation, and where anything is reported it's a general sense of less heaviness after hard training.
- The overlooked benefit
- The sweet white flesh carries almost none of the xanthones. They sit in the thick purple rind, so a fruit juice and a rind extract are different materials.
200 to 500mg a day is where Mangosteen works.
Source: Udani et al., Nutr J 2009; xanthone content research
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 10 human trials.
- markers of a healthy inflammatory responseRandomised trial
- blood antioxidant capacityRandomised trial
- immune cell marker changesRandomised trial
- NRF2-linked antioxidant enzyme expressionIn vitro study
- xanthone absorption and phase II conjugationNarrative review
Questions people ask about Mangosteen.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Alpha-mangostin undergoes heavy glucuronidation and intestinal efflux. Piperine slows both, so more of the xanthone reaches circulation intact.
Xanthones are poorly water soluble and depend on a lipid phase for micellar uptake. A fat carrier raises the absorbed fraction from a dry extract.
Ascorbate reduces phenoxyl radicals formed when xanthones donate an electron, returning them to the parent form. This is the same recycling relationship ascorbate has with other plant phenolics.
A randomised double-blind trial tested a propolis and mangosteen extract complex against placebo and reported changes in gum health measures in the treated group. Both materials carry polyphenolic constituents with described antioxidant and anti-inflammatory activity in laboratory systems, which is the shared rationale. Because the trial tested the complex, the finding belongs to the combination and cannot be attributed to either component alone.
Alpha-mangostin and its related xanthones are poorly water soluble, which is the main constraint on how much reaches circulation from an oral dose. Phospholipid dispersions and lecithin-based delivery are the standard formulation answer to that class of problem. The pairing addresses solubility, not potency, and it does not add any activity of its own.
Quercetin and mangosteen xanthones are both handled by phase II conjugation, principally glucuronidation and sulfation in the gut wall and liver, and both are radical-scavenging in laboratory assays. Placing them together loads the same conjugating capacity, which can change the free fraction of either. The effect is on handling rather than on any measured shared outcome.
Tocopherols work in the lipid phase of membranes while polyphenolic xanthones are mostly active at the lipid-water interface and in aqueous compartments. Antioxidant networks of this kind are described in terms of one species regenerating another after it quenches a radical. This is established chemistry in model systems and is not the same thing as a measured effect in people.
Curcuminoids and xanthones share the same practical problem of low aqueous solubility and heavy first-pass conjugation, so they end up in the same kinds of lipid or phospholipid delivery systems. They also compete for the same glucuronidation capacity. Formulators pair them for the botanical polyphenol story; the interaction that is actually documented is the shared metabolic route.
Catechins are extensively glucuronidated and sulfated, and they also inhibit some of the same conjugating enzymes, so co-dosing with another polyphenol class can raise the unconjugated fraction of both. That is a pharmacokinetic interaction, not an additive benefit. It is worth flagging in a blend precisely because the direction of change is not obvious from the label.
A randomised controlled study in women with excess body weight reported an effect of mangosteen extract on insulin sensitivity markers. Chromium acts on the same normal glucose-handling machinery through a separate route. Stacking two agents that touch glucose handling is worth flagging for anyone already managing blood sugar with medical supervision, and insulin sensitivity indices are markers rather than outcomes.
Berberine has well described activity on AMPK-linked glucose handling, and mangosteen extract has been reported to affect insulin sensitivity markers in a randomised study. Two agents pulling in the same direction on blood sugar is a flag for anyone whose blood sugar is already being managed, not a recommendation to combine. The marker level is where the data sits.
Cinnamon and mangosteen extract are both used in formulas aimed at normal blood sugar support, and each has human data at the marker level rather than the outcome level. Combining them stacks the same intended direction. No combination trial has tested the two together, so this is a formulation-level flag.
Alpha-lipoic acid moves between oxidised and reduced forms in both water-soluble and lipid-soluble environments, which is why it is described as a regenerator of other antioxidants. Pairing it with a phenolic plant extract fits that same network logic. The support is mechanistic and drawn from laboratory chemistry rather than from a combination trial.
Nothing specific on file for Mangosteen. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Mangosteen actually does.
The characterised actives of mangosteen sit in the pericarp, the thick purple rind, not the white edible aril; alpha-mangostin and gamma-mangostin are the xanthones that extracts are standardised on.
Xanthones are prenylated polyphenols with low aqueous solubility, so oral absorption depends heavily on the delivery format and on the presence of dietary fat.
Absorbed xanthones undergo extensive phase II conjugation, mainly glucuronidation and sulfation in the intestinal wall and liver, so circulating levels of the free aglycone stay low relative to the conjugates.
Whole-fruit juice products draw much of their polyphenol content from pericarp included during pressing, so a juice and a standardised pericarp extract are not comparable on a millilitre-for-milligram basis.
Where Mangosteen comes from.
The active compounds sit in the thick purple rind, not the white fruit inside. For an extract, the rind is dried, ground and washed with alcohol to pull the xanthones out, then concentrated, measured and dried into a powder. Juices and whole-fruit powders use the whole fruit, which means far less of the xanthone material per serving.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
The fruit is grown in humid tropical regions of Southeast Asia and harvested ripe; the deep purple pericarp is the fraction that carries the xanthones.
For extract production the rind is separated from the white edible flesh, dried and milled; whole-fruit products skip this separation and press or dry everything together.
Ethanol or aqueous ethanol is used to pull the prenylated xanthones out of the milled rind, since these constituents are poorly soluble in water alone.
The extract is filtered and the solvent is removed under reduced pressure, leaving a concentrated resinous mass.
The concentrate is assayed, commonly by HPLC, and blended with a carrier to reach a declared percentage; which marker is declared varies between suppliers.
The standardised material is dried onto a carrier for capsules and tablets, or dispersed into a lipid or phospholipid vehicle where solubility is the priority.
Getting Mangosteen from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Only two human studies in adults with raised blood sugar met inclusion, so the evidence base is very small: a randomised pilot trial reported a larger improvement in insulin sensitivity after 26 weeks of standardised mangosteen extract (HOMA-IR -53.2% versus -15.2%), and a small non-randomised study reported lower fasting glucose after 7 days.Systematic review. Purwoko et al., 2026 (Acta medica Indonesiana). PMID 41978307 ↗
- In 12 healthy adults, a single 250 mL mangosteen-based drink an hour before cycling showed no detectable difference from placebo in time to exhaustion, heart rate, perceived exertion or fatigue-related blood markers, with only a mood-score difference.Randomised trial. Chang et al., 2016 (Journal of the International Society of Sports Nutrition). PMID 27152103 ↗
- A propolis and mangosteen extract complex was compared with placebo in a randomised double-blind design, with the authors reporting improvement in the gum-health measures they tracked; the result belongs to the complex, not to mangosteen alone.Randomised trial. Jung JS et al., 2024 (Nutrients). PMID 39275315 ↗
- In a prospective randomised controlled design, mangosteen extract was reported to affect insulin sensitivity indices; insulin sensitivity is a marker, not a clinical outcome.Randomised trial. Watanabe M et al., 2018 (Nutrients). PMID 29747432 ↗
- Polyphenol-rich mangosteen pericarp extract reduced metabolic and reproductive disturbances induced by a high-fat diet in the animal model used, which is mechanistic support and does not carry across to people.Animal study. Ibrahim NAS et al., 2026 (Applied Biochemistry and Biotechnology). PMID 42250064 ↗
- A nanoencapsulated mangosteen rind extract used as a feed additive was associated with changes in growth performance and blood lipid measures in the animals studied.Animal study. Kusmayadi A et al., 2025 (Open Veterinary Journal). PMID 40989614 ↗
- This systematic review of plants and phytonutrients acting on the hypothalamic-pituitary-adrenal axis names mangosteen among the reviewed materials; the review reports the state of the human literature rather than testing mangosteen itself.Systematic review. Lopresti AL et al., 2022 (Nutritional Neuroscience). PMID 33650944 ↗
- A phytogenic feed additive containing mangosteen material among its components was associated with changes in gut-health and antioxidant capacity measures in the birds studied; the additive was multi-component.Animal study. Lee JH et al., 2026 (Poultry Science). PMID 41855797 ↗
- Phytonutrient-based tropical plant supplementation, mangosteen included among the plant materials, was reported to alter rumen fermentation characteristics.Animal study. Phesatcha B et al., 2026 (Animal Bioscience). PMID 40575976 ↗
- Dietary alpha-mangostin, the characterised xanthone of mangosteen pericarp, was associated with changes in oviduct inflammatory markers and eggshell quality in aging birds; this is an isolated constituent in an animal production model.Animal study. Huang L et al., 2026 (Animals). PMID 41976097 ↗
These are the studies our verdict leans on, chosen from the 482 we read for Mangosteen. The full linked list is below.
The studies, linked.
6 sources behind our Mangosteen verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialMangosteen Effects on Inflammatory Markers in Atrial Fibrillation TrialClinicalTrials.gov ↗PHASE1 · 143 participants · Terminated
- Clinical trialEvaluation of the Efficacy of Mangoselect®, a Mangosteen Extract, and of a Formulation Containing Mangoselect®, in Subjects Suffering From Activity/Exercise-induced Knee Joint Discomfort During a 12-week Supplementation Period. A Double-blind, Randomized, Multi-arm, Parallel and Placebo-controlled Study.ClinicalTrials.gov ↗NA · 95 participants · Completed
- Clinical trialEvaluation the Effect of Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Type 2 Diabetic Iraqi PatientsClinicalTrials.gov ↗NA · 58 participants · Completed
- Clinical trialClinical And Microbiological Efficacy Of 4% Garcinia Mangostana L.Pericarp Gel As A Local Drug Delivery In The Treatment Of Chronic Periodontitis: A Randomized Controlled Clinical TrialClinicalTrials.gov ↗NA · 50 participants · Completed
- Clinical trialEvaluation of Absorption and Metabolism of Phenolic Compounds From Mangoselect®, an Extract of Mangosteen. Comparison of Two Versions During a Randomized, Double-blinded and Cross-over TrialClinicalTrials.gov ↗NA · 10 participants · Completed
- Clinical trialInhibition and Cytotoxic Effects of Mangosteen on Cell LinesClinicalTrials.gov ↗NA · 2 participants · Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 39 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Mangosteen is, not how risky it is. A report is not proof Mangosteen caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.